WASHINGTON |
Fri Dec 7, 2012 12:01pm EST
WASHINGTON (Reuters) – A U.S. congressional cabinet that oversees drug reserve issues has asked a compounding pharmacists’ attention organisation to yield papers on a group’s purpose in assisting pharmacies in their interactions with sovereign and state authorities.
The ask to a International Academy of Compounding Pharmacists came as a House Energy and Commerce Committee continues an review into a lethal meningitis conflict caused by infested compounded drugs.
In a minute expelled on Friday, 10 lawmakers cited a media news that a organisation “tutored pharmacists on how to sidestep” U.S. Food and Drug Administration requests for samples that would assistance a group consider a peculiarity of compounded drugs.
“Allegations that your organisation might have speedy compounding pharmacists to try to block a FDA from evaluating a efficiency and reserve of their products, if true, lift critical concerns,” a lawmakers said.
The meningitis outbreak, related to steroid injections from a Massachusetts-based New England Compounding Center, has disgusted 541 people, 36 of whom have died, according to a U.S. Centers for Disease Control and Prevention.
(Reporting by Ros Krasny; Editing by Lisa Von Ahn)